160 related articles for article (PubMed ID: 22294841)
1. Adenovirus-expressed preS2 antibody inhibits hepatitis B virus infection and hepatic carcinogenesis.
Zhang Q; Li ZQ; Liu H; Yang JH
World J Gastroenterol; 2012 Jan; 18(4):349-55. PubMed ID: 22294841
[TBL] [Abstract][Full Text] [Related]
2. The Strategy of Conditionally Replicating Adenovirus-Mediated PreS2 Mini-Antibody Expression Has Dual Effects of Inhibiting HBV Infection and Preventing Hepatocellular Carcinoma.
Ye Z; Zeng S; Xu P; Liu W; Wang S; Xia X; Su C; Guo M
Cancer Manag Res; 2021; 13():1869-1876. PubMed ID: 33658851
[TBL] [Abstract][Full Text] [Related]
3. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
[TBL] [Abstract][Full Text] [Related]
4. Sex disparity in viral load, inflammation and liver damage in transgenic mice carrying full hepatitis B virus genome with the W4P mutation in the preS1 region.
Lee SA; Lee SY; Choi YM; Kim H; Kim BJ
World J Gastroenterol; 2018 Mar; 24(10):1084-1092. PubMed ID: 29563753
[TBL] [Abstract][Full Text] [Related]
5. An anti-preS2 antibody protects human hepatocytes from hepatitis B virus infection.
Guo M; Kang B; Zheng Q; Qian Q; Su C; Wu M; Yang J
Acta Gastroenterol Belg; 2009; 72(3):306-11. PubMed ID: 19902863
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
Yang WT; Wu LW; Tseng TC; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Liu CJ; Kao JH
Medicine (Baltimore); 2016 Mar; 95(10):e2995. PubMed ID: 26962809
[TBL] [Abstract][Full Text] [Related]
9. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
10. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection.
Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P
Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143
[TBL] [Abstract][Full Text] [Related]
12. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
Fei GZ; Sylvan SP; Hellström UB; Yao GB
J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501
[TBL] [Abstract][Full Text] [Related]
14. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
[TBL] [Abstract][Full Text] [Related]
16. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instability.
Yen TT; Yang A; Chiu WT; Li TN; Wang LH; Wu YH; Wang HC; Chen L; Wang WC; Huang W; Chang CW; Chang MD; Shen MR; Su IJ; Wang LH
Oncotarget; 2016 Apr; 7(17):23346-60. PubMed ID: 26992221
[TBL] [Abstract][Full Text] [Related]
18. HBsAg-negative hepatitis B virus infection and hepatocellular carcinoma.
Chen L; Zhao H; Yang X; Gao JY; Cheng J
Discov Med; 2014 Oct; 18(99):189-93. PubMed ID: 25336032
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B viral infection: part I. Clinical features.
Dzik WH; Alter HJ
Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
[TBL] [Abstract][Full Text] [Related]
20. Breaking Hepatitis B Virus Tolerance and Inducing Protective Immunity Based on Mimicking T Cell-Independent Antigen.
Li X; Ni R
Viral Immunol; 2016 Nov; 29(9):502-509. PubMed ID: 27662269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
